Not recruiting
Cardiomyopathy
Not recruitingStudy on the Safety and Effects of OMT-28 for Patients with Primary Mitochondrial Disease and Muscle or Heart Problems
InvestigationalNo placebo
Study on the Safety and Effects of OMT-28 for Patients with Primary Mitochondrial Disease and Muscle or Heart Problems
InvestigationalNo placebo
- Disease:Cardiomyopathy
- Substances:2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
Countries:
Germany
Germany- Participants:18–64 years
- Substances:2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
